Medindia

X

Cancer Breakthrough Reported by Novogen

by Kathy Jones on  April 9, 2013 at 9:00 PM Corporate News   - G J E 4
Australian drug company Novogen Limited revealed that it has succeeded in isolating the most potent form of its lead anti-cancer drug candidate, CS-6.
 Cancer Breakthrough Reported by Novogen
Cancer Breakthrough Reported by Novogen
Advertisement

Novogen revealed that CS-6 is a chiral molecule, a molecule that has a non-superposable mirror image, which means that it exists in both left and right-hand forms known as enantiomers.

Advertisement
The company revealed that isolating the most potent form of the drug will allow it to manufacture both left and right hand forms of enantiomers.

"The ability to manufacture CS-6 in both left- and right-hand forms represents a significant milestone in the development of this compound. The indication that one form of CS-6 is active at nanomolar concentrations against a broad spectrum of brain cancer lines is exciting and indicates that the earlier potencies we have seen against cancer cells and cancer stem cells are likely to be even greater with the purified enantiomer. We are now positioned to rapidly progress CS-6 to the clinic", Novogen Chief Scientific Officer Dr Andrew Heaton said.

Source: Medindia
Advertisement

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
Notify me when reply is posted I agree to the terms and conditions

You May Also Like

Advertisement
View All